DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Blue Jet Healthcare Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·8 Oct 2026, 5:50 am

Blue Jet Healthcare

Blue Jet Healthcare Limited has informed stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company has met the necessary requirements for its depository participant (DP) operations.

For investors, this development is a routine procedural update rather than a significant market-moving event. It signals that the company's shareholding and dematerialization processes are operating within the framework of SEBI rules, which is a standard expectation for listed entities.

Investors should monitor the company's future quarterly reports to see if this compliance leads to any operational improvements or changes in share transfer timelines. This filing primarily serves as a confirmation of existing regulatory adherence.